Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

View:
Post by Verygood007 on Jan 23, 2019 5:10pm

$2.18 low

This might go to $2.18. Watch out.
Comment by hpjtv77 on Jan 23, 2019 10:33pm
What do you base this on?   Who cares about your opinion!
Comment by Cdubdub on Jan 24, 2019 6:16am
OR it could break out of the FW it’s in and hit mid $3. Do you even TA or are you getting your analysis from someone who wants your shares for cheap?  Thanks for your update - sentiment is useful. 
Comment by Verygood007 on Jan 24, 2019 4:28pm
Don’t know how to do TA. How shall I learn? Only thing I know is only good news or results can help it move up.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities